Research & News
By Al Qureiyeh On October 21, 202601:20 PM Eastern
I'd buy Bristol-Myers Squibb, a "B-" BUY that pays about 4% while you wait.
By Chris Graebe On October 21, 202601:20 PM Eastern
Plus, your last chance to join me in person in 2026 is just ahead!
By Al Qureiyeh On October 21, 202601:00 PM Eastern
These 2 financial stocks are set to rip higher.
By Michael A. Robinson On October 21, 202611:51 AM Eastern
The news doesn’t show the full story behind the AI buildout.
By Sean Brodrick On October 21, 202610:30 AM Eastern
From copper production to high-grade gold discoveries, these three miners offer intriguing growth potential.
Weiss Income Multiplier
Subscription
By Nilus Mattive On October 21, 202609:52 AM Eastern
Here’s how we’ll continue to sail through it.
By David Phillips On October 21, 202609:15 AM Eastern
Put part of your retirement savings out of the stock market’s reach, with up to 10% annual liquidity.
By Sean Brodrick On October 21, 202607:00 AM Eastern
This fund gives you exposure to the one thing CEOs can’t cut spending on.
By Al Qureiyeh On October 20, 202602:05 PM Eastern
I'd own Berkshire Hathaway, an "A-" BUY, rather than add more to an index fund.
By Sean Brodrick On October 20, 202612:35 PM Eastern
I went to Beaver Creek to uncover opportunities. These three miners stood out.